Dense Breasts and Breast Cancer Risk

What is breast density?

Breast tissue is a mixture of fat, glandular tissue (milk-producing) and fibrous connective tissue. Breast density measures how much of the breast is glandular and fibrous compared to fatty tissue. On a mammogram X-ray, glandular and fibrous tissue appear white, as do potential tumours — while fat appears dark. This overlap is the core challenge of dense tissue.

BI-RADS density categories

Radiologists use the BI-RADS (Breast Imaging Reporting and Data System) classification:

• Category A — Almost entirely fatty: less than 25% glandular tissue. Easiest for mammography to read.
• Category B — Scattered fibroglandular density: 25–50% glandular tissue.
• Category C — Heterogeneously dense: 51–75% glandular tissue. Most common in women of screening age.
• Category D — Extremely dense: over 75% glandular tissue. Most challenging for mammography.

Around 40% of women of mammography screening age fall into Category C or D — what is commonly referred to as "dense breasts." Density tends to decrease with age but varies significantly between individuals. It is not something you can feel or notice yourself.

Why dense breasts matter: two separate risks

• Masking effect: dense tissue and potential tumours both appear white on mammogram X-ray, making cancers harder to spot. Mammogram sensitivity can be reduced by 30–40% in extremely dense breasts. Cancers in dense tissue are significantly more likely to be "interval cancers" — found due to symptoms between screening rounds rather than at the screening itself.
• Independent cancer risk: dense breast tissue itself raises breast cancer risk by approximately 1.6–2 times, independent of the masking effect. This is thought to relate to the higher proportion of dividing glandular cells in which mutations can occur.

The NHS position on breast density

In the UK, there is currently no mandatory requirement to notify women of their breast density following an NHS mammogram. Radiologists take density into account when reading mammograms, and women with extremely dense tissue may receive supplemental imaging at clinical discretion. However, patients are not routinely informed. You can ask your GP or breast screening unit about your density, especially with additional risk factors.

What to do if you have dense breasts

• Ask your GP or breast screening unit about your density — especially with family history or other risk factors.
• Continue attending NHS mammogram invitations. Mammography remains the best available screening tool even in dense tissue.
• Practice regular breast self-awareness (Touch–Look–Check) — especially important if you have dense breasts.
• Discuss supplemental screening if appropriate for your overall risk profile.

Supplemental screening options

• Ultrasound: can detect cancers not visible on mammogram in dense tissue. Widely available. Higher false-positive rate than mammography.
• Contrast-enhanced mammography (CEM): uses contrast dye to highlight areas of increased blood flow. Better sensitivity than standard mammography in dense tissue. Available in some NHS centres.
• MRI: the most sensitive supplemental screening tool, but expensive and reserved in the NHS for women at high hereditary risk (BRCA carriers and others).
• Tomosynthesis (3D mammography): layered images that reduce the masking effect of dense tissue. Increasingly available on the NHS.

Dense tissue is universal — access to imaging is not

Around 40% of women worldwide have dense breasts. The challenge this creates for mammographic detection is the same no matter where a woman lives. In the UK, eligible women receive an NHS mammogram. In low-income countries, she is almost certainly never offered a mammogram at all. The mobile screening units funded by donations to Breast Cancer Charity deliver clinical breast examination and ultrasound to communities that have no other option. Your donation of £25 funds one of those screenings.